FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Astellas Pharma US Tarceva Recall

Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremer…

Astellas Pharma US Inc · Northbrook, IL

Risk level
Class II
Reported by FDA
Oct 15, 2014
Recall ID
D-0008-2015
Check your lot numberHow we source this data

Summary

Astellas Pharma US recalled Tarceva starting Sep 15, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0008-2015 on Oct 15, 2014. Reason: Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.

Product description

Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01

Lot numbers, UPCs & expiration codes

Lot 66482CW, Exp 04/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0008-2015
Classification
Class II
Status
Terminated
Recall initiated
Sep 15, 2014
FDA report date
Oct 15, 2014
Quantity
9,236 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Astellas Pharma US Inc

Original FDA data

Every field from FDA enforcement report D-0008-2015, exactly as published.

Show all FDA fields
City
Northbrook
State
IL
Status
Terminated
Country
United States
Event ID
69246
Address
1 Astellas Way
Code information
Lot 66482CW, Exp 04/16
Postal code
60062-6111
Report date
Oct 15, 2014
Product type
Drugs
Recall number
D-0008-2015
Classification
Class II
Recalling firm
Astellas Pharma US Inc
Product quantity
9,236 bottles
Termination date
May 19, 2015
Reason for recall
Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01
Distribution pattern
Nationwide
Recall initiation date
Sep 15, 2014
Initial firm notification
Letter
Center classification date
Oct 7, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0008-2015, published Oct 15, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls